MESO — Mesoblast Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	60	70.9	62.6	161	47.4
Net Total Accounts Receivable
Net Total Receivables	4.4	7	3.4	14.9	57.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	69.8	81.7	86.5	204	197
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.96	6.49	3.84	5.82	8.01
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	662	669	669	785	773
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	51.4	42	73.2	103	81.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	165	168	189	187	205
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	497	502	480	597	568
Total Liabilities & Shareholders' Equity	662	669	669	785	773
Total Common Shares Outstanding